European Journal of Pharmacology, volume 880, pages 173182

Calcium signaling mediated by aminergic GPCRs is impaired by the PI3K inhibitor LY294002 and its analog LY303511 in a PI3K-independent manner

Publication typeJournal Article
Publication date2020-08-01
Quartile SCImago
Q1
Quartile WOS
Q1
Impact factor5
ISSN00142999, 18790712
Pharmacology
Abstract
The phosphoinositide 3-kinase (PI3K) inhibitor LY294002 (LY294) and its much less active analog LY303511 (LY303) constitute the paired probe that is commonly used to demonstrate the involvement of PI3K in intracellular signaling. We studied effects of LY294 and LY303 on Ca2+ signaling initiated by certain GPCR agonists in cells of several lines, including CHO cells expressing the recombinant serotonin receptor 5-HT2C and mesenchymal stromal cells derived from the human adipose tissue (AD-MSCs) and umbilical cord (UD-MSCs). The LY294/LY303 pair exerted apparently specific effects on responsiveness of AD-MSCs to ATP, suggesting the involvement of PI3K in ATP transduction. Surprisingly, LY303 inhibited Ca2+ transients elicited by histamine in the same cells, while LY294 was ineffective. This observation and other findings implicated a PI3K-unrelated mechanism in mediating effects of the LY compound on AD-MSC responsiveness to histamine. With LY303 in the bath, the dose dependence of histamine responses was shifted positively at the invariable number of responsive cells, as would be the case with a competitive antagonist of histamine receptors. Moreover, LY303 and LY294 inhibited Ca2+ transients elicited by acetylcholine and serotonin in UD-MSCs and CHO/5-HT2C cells, respectively. Our overall results argued for the possibility that LY294 and LY303 could directly affect activity of aminergic GPCRs. Thus, LY303511 and LY294002 should be used cautiously in studies of PI3K as a factor of GPCR signaling.

Citations by journals

1
Stem Cells and Development
Stem Cells and Development, 1, 12.5%
Stem Cells and Development
1 publication, 12.5%
NeuroReport
NeuroReport, 1, 12.5%
NeuroReport
1 publication, 12.5%
Cells
Cells, 1, 12.5%
Cells
1 publication, 12.5%
BBA Advances
BBA Advances, 1, 12.5%
BBA Advances
1 publication, 12.5%
Food Science and Nutrition
Food Science and Nutrition, 1, 12.5%
Food Science and Nutrition
1 publication, 12.5%
Reproduction, Fertility and Development
Reproduction, Fertility and Development, 1, 12.5%
Reproduction, Fertility and Development
1 publication, 12.5%
Cellular Signalling
Cellular Signalling, 1, 12.5%
Cellular Signalling
1 publication, 12.5%
1

Citations by publishers

1
2
Elsevier
Elsevier, 2, 25%
Elsevier
2 publications, 25%
Mary Ann Liebert
Mary Ann Liebert, 1, 12.5%
Mary Ann Liebert
1 publication, 12.5%
Wolters Kluwer Health
Wolters Kluwer Health, 1, 12.5%
Wolters Kluwer Health
1 publication, 12.5%
Multidisciplinary Digital Publishing Institute (MDPI)
Multidisciplinary Digital Publishing Institute (MDPI), 1, 12.5%
Multidisciplinary Digital Publishing Institute (MDPI)
1 publication, 12.5%
Wiley
Wiley, 1, 12.5%
Wiley
1 publication, 12.5%
CSIRO Publishing
CSIRO Publishing, 1, 12.5%
CSIRO Publishing
1 publication, 12.5%
1
2
  • We do not take into account publications that without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
Kotova P. D. et al. Calcium signaling mediated by aminergic GPCRs is impaired by the PI3K inhibitor LY294002 and its analog LY303511 in a PI3K-independent manner // European Journal of Pharmacology. 2020. Vol. 880. p. 173182.
GOST all authors (up to 50) Copy
Kotova P. D., Kochkina E. N., Lyamin O. O., Rogachevskaja O. A., Korolenko N. P., Ivashin D. S., Bystrova M. F., Enukashvily N. I., Kolesnikov S. S. Calcium signaling mediated by aminergic GPCRs is impaired by the PI3K inhibitor LY294002 and its analog LY303511 in a PI3K-independent manner // European Journal of Pharmacology. 2020. Vol. 880. p. 173182.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1016/j.ejphar.2020.173182
UR - https://doi.org/10.1016%2Fj.ejphar.2020.173182
TI - Calcium signaling mediated by aminergic GPCRs is impaired by the PI3K inhibitor LY294002 and its analog LY303511 in a PI3K-independent manner
T2 - European Journal of Pharmacology
AU - Kotova, Polina D
AU - Kochkina, Ekaterina N
AU - Lyamin, Oleg O
AU - Rogachevskaja, Olga A
AU - Korolenko, Nina P
AU - Ivashin, Denis S
AU - Bystrova, Marina F.
AU - Enukashvily, N. I.
AU - Kolesnikov, Stanislav S
PY - 2020
DA - 2020/08/01 00:00:00
PB - Elsevier
SP - 173182
VL - 880
SN - 0014-2999
SN - 1879-0712
ER -
BibTex
Cite this
BibTex Copy
@article{2020_Kotova,
author = {Polina D Kotova and Ekaterina N Kochkina and Oleg O Lyamin and Olga A Rogachevskaja and Nina P Korolenko and Denis S Ivashin and Marina F. Bystrova and N. I. Enukashvily and Stanislav S Kolesnikov},
title = {Calcium signaling mediated by aminergic GPCRs is impaired by the PI3K inhibitor LY294002 and its analog LY303511 in a PI3K-independent manner},
journal = {European Journal of Pharmacology},
year = {2020},
volume = {880},
publisher = {Elsevier},
month = {aug},
url = {https://doi.org/10.1016%2Fj.ejphar.2020.173182},
pages = {173182},
doi = {10.1016/j.ejphar.2020.173182}
}
Found error?